Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT05868291

Daylight-controlled Lighting Adjusted for Geographical Orientation : Effects on Recovery, Energy Consumption and User Satisfaction

The trial takes place in 4 psychiatric closed wards at Ny Psykiatri Bispebjerg. The objective is to compare, retrospectively, over two consecutive winter periods (2022 and 2023) the effect of the lighting on the duration of stay of the patients. During the first winter, a standard lighting is used, and, during the second winter, the lighting will be modified to favor a greater light intensity in blue wave color light in the morning and a gradual decrease in light intensity in the evening adjusted for geographical orientation of the patients' rooms.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Conditions

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Ny Psykiatri Bispebjerg, Copenhagen, Region Sjælland, Denmark

Loading trial locations.

About this study

Light has benefits in many pathologies, especially in psychiatry and sleep disorders. It is the most powerful Zeitgeber, allowing a drive of the sleep-wake rhythm. But what are the "doses or quantities" of light necessary for humans to stimulate circadian regulation? And how is it possible to promote better people's exposure to this amount of light during winter (especially in Nordic countries where daily light exposure during winter is particularly reduced: 8 hours on average)? At the Bispebjerg Hospital, following the installation of LED lighting, a dynamic system favoring a greater light intensity in blue wave color light in the morning and a gradual decrease in light intensity in the evening adjusted for geographical orientation of the patients' rooms is evaluated. This device was effective on anxious and depressive symptoms for patients hospitalized after a stroke. Here, we'll study the effect the light may have on patients in psychiatric closed wards. Moreover, we'll assess the users' satisfaction and the energy consumption of the system.

If the described intervention is associated with a reduction in the duration of stay of the patients in the ward as well as with a general satisfaction of the users and that it consumes much less energy, one could think of the installation of this system on a large scale not only in hospitals but also in schools or other public buildings where it could be interesting to have this adapted lighting.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients being 18 years old or older
  • patients having a duration of stay of at least 3 days in the wards

Exclusion criteria

  • patients that have switched room during their stay
  • patients that have been in rooms where the lighting wasn't working

Treatment and study plan

Primary outcomes

  1. Duration of stay

    Time frame: The 2 periods consecutive winter period (2022 and 2023)

    Number of day of the stay of the partient in the closed ward of NPB (Ny Psykiatri Bispebjerg)

Secondary outcomes

  1. Use of psychotropic medication

    Time frame: The 2 periods consecutive winter period (2022 and 2023)

    The mean use of psychotropic medication (in mg/day) during the two periods

Sponsors and collaborators

Lead sponsor

Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital

Other

Collaborators

  • Elforsk

Registry information

Acronym: DIM Light

Important dates

Study start
2022
Primary completion
2026
Study completion
2026
First posted
May 22, 2023
Registry last updated
May 11, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.